Debogy Molecular Announces New Capital Raise To Bring Innovative Antimicrobial Technology To Market
FARMINGTON, Conn. — November 19, 2024 — DeBogy Molecular, Inc, a privately held biotech that specializes in antimicrobial surface modification, announced their Board of Directors has approved a new capital… Read More »Debogy Molecular Announces New Capital Raise To Bring Innovative Antimicrobial Technology To Market